Thurston Springer Miller Herd & Titak Inc. Purchases 755 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thurston Springer Miller Herd & Titak Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,913 shares of the medical equipment provider’s stock after purchasing an additional 755 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.’s holdings in Intuitive Surgical were worth $998,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Park Avenue Securities LLC grew its position in shares of Intuitive Surgical by 5.2% during the fourth quarter. Park Avenue Securities LLC now owns 15,724 shares of the medical equipment provider’s stock worth $8,207,000 after purchasing an additional 784 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in Intuitive Surgical by 9.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,571,273 shares of the medical equipment provider’s stock valued at $820,142,000 after buying an additional 129,363 shares in the last quarter. Board of the Pension Protection Fund bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $1,044,000. Fifth Third Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 10.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 9,245 shares of the medical equipment provider’s stock worth $4,826,000 after buying an additional 907 shares in the last quarter. Finally, SeaCrest Wealth Management LLC boosted its position in shares of Intuitive Surgical by 2.2% during the fourth quarter. SeaCrest Wealth Management LLC now owns 1,982 shares of the medical equipment provider’s stock worth $1,035,000 after acquiring an additional 42 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 7.7 %

ISRG opened at $580.11 on Thursday. The business has a fifty day moving average of $537.05 and a 200 day moving average of $496.50. The stock has a market cap of $206.62 billion, a P/E ratio of 93.27, a PEG ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $584.60.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. The trade was a 88.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have issued reports on ISRG. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.